Published in Vet Rec on March 01, 2014
History of One Health and One Medicine. Vet Rec (2014) 1.08
History of One Health and One Medicine. Vet Rec (2014) 0.75
History of One Health and One Medicine. Vet Rec (2014) 0.75
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Abnormal vocal cord function in difficult-to-treat asthma. Am J Respir Crit Care Med (2011) 2.27
Cardiac compromise due to a pancreatic mediastinal pseudocyst. Eur J Gastroenterol Hepatol (2002) 1.22
Parsing ecological signal from noise in next generation amplicon sequencing. New Phytol (2014) 1.15
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol (2002) 0.95
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol (2004) 0.95
Complete recovery following a high voltage electrical injury associated with delayed onset of quadriplegia and multiple cranial nerves dysfunction. Burns (2004) 0.93
Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J Neurovirol (2005) 0.92
Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J Virol (2002) 0.87
Vancomycin pharmacokinetics in patients with severe burn injuries. Burns (2009) 0.87
Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J Feline Med Surg (2006) 0.85
Comparison of sleep disturbance in mild versus severe Parkinson's disease. Sleep (2002) 0.85
Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet Immunol Immunopathol (2002) 0.85
Multiple accountabilities in incident reporting and management. Qual Health Res (2010) 0.84
Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge. Antiviral Res (2010) 0.84
Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management. ANZ J Surg (2007) 0.84
System-wide learning from root cause analysis: a report from the New South Wales Root Cause Analysis Review Committee. Qual Saf Health Care (2010) 0.82
Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine (2002) 0.82
Early in-hospital management of burn injuries in Australia. ANZ J Surg (2004) 0.81
Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence. J Feline Med Surg (2011) 0.80
Development of antibodies to feline IFN-gamma as tools to elucidate the cellular immune responses to FeLV. J Immunol Methods (2003) 0.80
A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus. Vaccine (2005) 0.80
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J Virol (2005) 0.80
Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat. Cytokine (2002) 0.79
Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus. Vaccine (2006) 0.79
Effect of interferon gamma and CD40 ligation on intracellular monocyte survival of nontypeable Haemophilus influenzae. APMIS (2008) 0.79
Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis. APMIS (2009) 0.78
Electrical flash burns due to switchboard explosions in New South Wales--a 9-year experience. Burns (2011) 0.78
In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin. Australas J Dermatol (2013) 0.78
Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies. J Clin Oncol (2006) 0.78
Quality evaluation of meshed split-thickness skin grafts stored at 4°C in isotonic solutions and nutrient media by cell cultures. Burns (2012) 0.78
Emergency endovascular repair of acute descending thoracic aortic dissection. Vasc Health Risk Manag (2007) 0.77
Evaluation of an in-practice test for feline coronavirus antibodies. J Feline Med Surg (2004) 0.76
Treatment of a persistent false lumen with aneurysm formation following surgical repair of type a dissection. Cardiovasc Intervent Radiol (2007) 0.75
A molecular and morphological analysis of the genus Rhizopogon subgenus Villosuli section Villosuli as a preface to ecological monitoring. Mycologia (2014) 0.75
A multi-tiered approach to safety education. Clin Teach (2013) 0.75
Samples with high virus load cause a trend toward lower signal in feline coronavirus antibody tests. J Feline Med Surg (2012) 0.75
Setting new thermal standards for transitional and coastal (TraC) waters. Mar Pollut Bull (2012) 0.75